Yea - the primary reason I purchased stock this AM is because of the sales numbers. If you adjust for EUR/USD they are around $1.8 million which is up pretty significantly from $1 million the last several quarters. Hopefully we see sales around $2.0 million or in Q1 or Q2 2016. I believe that would be a good catalyst for a stock price run-up back to $6-$7. It seems that with an expanding list of countries the product is approved in and re-curring orders, they should build a nice base. We shall see...